Sep 02, 2016
Press Release – For Immediate Release
Visante Audit Validates ScriptPro Real Time 340B Processing
MISSION, KS – ScriptPro announces that its unique real time 340B processing system has successfully passed an intensive audit performed at University of Kentucky by Visante Inc. Visante is a leading firm in 340B audit and compliance support and is completely independent with no fiduciary relationship to ScriptPro or any other split-billing vendors. The audit covered over 100,000 prescriptions processed in UK pharmacies during the first half of 2016. According to Gary Johnson, Chief Pharmacy Officer of UK, "The audit confirms what we already knew. We can rely on the accuracy of ScriptPro's real time processing system to ensure compliance with complex 340B regulations."
Jim Jorgenson, Chief Executive Officer of Visante, commends ScriptPro saying, "Visante congratulates ScriptPro for recognizing the critical value of the 340B Drug Pricing Program and for the decision to have its system evaluated by external, independent consultants." The audit report concludes, "Visante feels confident that with continued focus on the 340B Program, and with the support of covered entity partners, ScriptPro will continue to provide a successful and compliant software solution to UK and other customers."
ScriptPro's real time 340B compliance engine differs from after-the fact-processing methods used by other split-billing systems. According to Mike Coughlin, ScriptPro's President and CEO, "Our 340B determinations are made by the pharmacy management system as prescriptions are filled. The system can then automatically direct staff to use 340B drug stock for qualified prescriptions. And it provides a basis for direct verification of prescription transactions rather than through analysis of aggregate data accumulations."
Johnson concurs with the importance of a transaction based approach. He says, "As stated in the Visante report, ScriptPro goes beyond the capabilities of other split-billing vendors when its qualifying logic can extend to considering the locations where prescriptions are written. This supports both flexibility and accuracy in qualifying prescriptions for 340B."
ABOUT SCRIPTPRO: ScriptPro provides a comprehensive, integrated platform of robotics-enabled systems to optimize retail and ambulatory pharmacy operations, promoting safe and effective medication use, including automated inventory management, telepharmacy integration, and support for specialty pharmacy services, high-risk/high cost medications, 340B dispensing, and third party financial management. For more information, go to www.scriptpro.com.
ABOUT VISANTE: Visante, with offices in the U.S., Canada, and the United Kingdom, provides medicines management consulting to a wide variety of healthcare entities, including hospitals, health systems, managed care organizations, health IT and technology firms, and pharmaceutical manufacturers. Visante helps clients optimize medication use, increasing the quality of patient care and managing costs. Founded in 1999, Visante is comprised of consultants who are pharmacists, physicians, nurses, finance, and IT professionals, each with 20 or more years of healthcare experience. Learn more at www.visanteinc.com.
|Jan 18, 2018||Winland Hires Manager of the Reseller Partner Channel|
|Jan 10, 2018||American Associated Pharmacies Selects FDS ECONCILE Reconciliation and Claims Ma...|
|Dec 27, 2017||RxOneShop Is Proud to Sponsor and Invite You to Pharmacy Owners Boot Camp|
|Dec 20, 2017||UPMC Chooses Revolutionary Technology from Omnicell to Elevate and Automate Phar...|
|Dec 18, 2017||Medicine-On-Time Announces Long-Term Distribution Partnership and Purchase of Ma...|
|Dec 14, 2017||iMedicare and Creative Pharmacist Announce Strategic Partnership|
|Dec 13, 2017||American BioTech Supply Introduces Webpages Dedicated to Natural Refrigerant Tec...|
|Dec 08, 2017||Azzur Labs Expands Accreditation|
|Dec 08, 2017||Azzur Labs Named Fourth Best Place To Work in PA|
|Dec 06, 2017||Hacettepe University Oncology Hospital Introduces Omnicell i.v.STATION ONCO Robo...|
|Dec 01, 2017||Swisslog Healthcare Launches Next-Generation Pharmacy Analytics Platform To Tran...|
|Nov 28, 2017||Omnicell Introduces Revolutionary New Solution to Automate Critical Workflows in...|
|Nov 22, 2017||R.J. Hedges & Associates Named 2017 Torch Award for Ethics by BBB|
|Nov 17, 2017||BestRx First Pharmacy Dispensing Software Company to Achieve Level 2 – Pharmac...|
|Nov 16, 2017||Introducing Accreditation Commission for Health Care as a Thought Leader in Phar...|
|Nov 15, 2017||Medi-Dose®, Inc. / EPS®, Inc. Now Markets Steri-Tamp® Tamper-Clear Syringe...|
|Nov 14, 2017||Omnicell Supports Global Charity Mercy Ships by Donating Next Generation XT Seri...|
|Nov 14, 2017||Medi-Dose, Inc. Announces NEW MPB™ Multi-Purpose Blister|
|Nov 13, 2017||OmniSYS Announces Strategic Partnership with PerceptiMed|
|Nov 02, 2017||Contec, Inc. Recognized as One of America's Healthiest Organizations by American...|
|Nov 02, 2017||Introducing Apexus as a Thought Leader in 340B Drug Pricing and Education|
|Oct 31, 2017||Medicine-On-Time and Clinical Support Services Announce the Formation of Star MT...|
|Oct 26, 2017||Hackensack Meridian Health Expands Contract with Omnicell for Medication Managem...|
|Oct 26, 2017||iMedicare and American Associated Pharmacies Partner to Help Independent Pharmac...|
|Oct 25, 2017||Medi-Dose, Inc. / EPS, Inc. Announces Expanded Line of Resealable and Ultraviole...|
|Oct 25, 2017||Riverside Medical Center Selects Omnicell's Medication Management Solutions to E...|
|Oct 25, 2017||Kinney Drugs 1st Patient-Centered Pharmacy Home™ Accreditation Recipient|
|Oct 24, 2017||Dana Rafferty Named Akro-Mils Executive Director of Sales and Marketing|
|Oct 23, 2017||Medi-Dose/EPS Announces TampAlerT® Tamper-Evident Cap for ENFit™ Syringes|
|Oct 20, 2017||Phononic Honored by Goldman Sachs for Entrepreneurship|
Connect with thousands of pharmacy professionals throughout every practice setting.